These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36977373)

  • 1. Analysis of the Proteomic Profile in Serum of Irradiated Nonhuman Primates Treated with Ex-Rad, a Radiation Medical Countermeasure.
    Carpenter AD; Li Y; Janocha BL; Wise SY; Fatanmi OO; Maniar M; Cheema AK; Singh VK
    J Proteome Res; 2023 Apr; 22(4):1116-1126. PubMed ID: 36977373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the metabolomic profile in serum of irradiated nonhuman primates treated with Ex-Rad, a radiation countermeasure.
    Li Y; Girgis M; Wise SY; Fatanmi OO; Seed TM; Maniar M; Cheema AK; Singh VK
    Sci Rep; 2021 Jun; 11(1):11449. PubMed ID: 34075191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum microRNA profile of rhesus macaques following ionizing radiation exposure and treatment with a medical countermeasure, Ex-Rad.
    Russ E; Fatanmi OO; Wise SY; Carpenter AD; Maniar M; Iordanskiy S; Singh VK
    Sci Rep; 2024 Feb; 14(1):4518. PubMed ID: 38402257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hematopoietic Syndrome of the Acute Radiation Syndrome in Rhesus Macaques: A Systematic Review of the Lethal Dose Response Relationship.
    MacVittie TJ; Farese AM; Jackson W
    Health Phys; 2015 Nov; 109(5):342-66. PubMed ID: 26425897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Metabolomic Serum Signature from Nonhuman Primates Treated with a Radiation Countermeasure, Gamma-tocotrienol, and Exposed to Ionizing Radiation.
    Pannkuk EL; Laiakis EC; Fornace AJ; Fatanmi OO; Singh VK
    Health Phys; 2018 Jul; 115(1):3-11. PubMed ID: 29787425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDX-301: a novel medical countermeasure for hematopoietic acute radiation syndrome in mice.
    Satyamitra M; Cary L; Dunn D; Holmes-Hampton GP; Thomas LJ; Ghosh SP
    Sci Rep; 2020 Feb; 10(1):1757. PubMed ID: 32019942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amelioration of radiation-induced hematopoietic and gastrointestinal damage by Ex-RAD(R) in mice.
    Ghosh SP; Kulkarni S; Perkins MW; Hieber K; Pessu RL; Gambles K; Maniar M; Kao TC; Seed TM; Kumar KS
    J Radiat Res; 2012 Jul; 53(4):526-36. PubMed ID: 22843617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation countermeasure agents: an update (2011-2014).
    Singh VK; Newman VL; Romaine PL; Wise SY; Seed TM
    Expert Opin Ther Pat; 2014 Nov; 24(11):1229-55. PubMed ID: 25315070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative proteomic analysis of serum from nonhuman primates administered BIO 300: a promising radiation countermeasure.
    Girgis M; Li Y; Ma J; Sanda M; Wise SY; Fatanmi OO; Kaytor MD; Cheema AK; Singh VK
    Sci Rep; 2020 Nov; 10(1):19343. PubMed ID: 33168863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of gamma-tocotrienol as a radiation medical countermeasure for the acute radiation syndrome: current status and future perspectives.
    Singh VK; Seed TM
    Expert Opin Investig Drugs; 2023 Jan; 32(1):25-35. PubMed ID: 36655861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological studies of nonhuman primates exposed to supralethal doses of total- or partial-body radiation: influence of a medical countermeasure, gamma-tocotrienol.
    Singh VK; Wise SY; Fatanmi OO; Petrus SA; Carpenter AD; Lee SH; Hauer-Jensen M; Seed TM
    Sci Rep; 2024 Mar; 14(1):5757. PubMed ID: 38459144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome profile changes in the jejunum of nonhuman primates exposed to supralethal dose of total- or partial-body radiation.
    Vellichirammal NN; Sethi S; Avuthu N; Wise SY; Carpenter AD; Fatanmi OO; Guda C; Singh VK
    BMC Genomics; 2023 May; 24(1):274. PubMed ID: 37217865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation protection by a new chemical entity, Ex-Rad: efficacy and mechanisms.
    Ghosh SP; Perkins MW; Hieber K; Kulkarni S; Kao TC; Reddy EP; Reddy MV; Maniar M; Seed T; Kumar KS
    Radiat Res; 2009 Feb; 171(2):173-9. PubMed ID: 19267542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegfilgrastim Improves Survival of Lethally Irradiated Nonhuman Primates.
    Hankey KG; Farese AM; Blaauw EC; Gibbs AM; Smith CP; Katz BP; Tong Y; Prado KL; MacVittie TJ
    Radiat Res; 2015 Jun; 183(6):643-55. PubMed ID: 26035709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ON01210.Na (Ex-RAD®) mitigates radiation damage through activation of the AKT pathway.
    Kang AD; Cosenza SC; Bonagura M; Manair M; Reddy MV; Reddy EP
    PLoS One; 2013; 8(3):e58355. PubMed ID: 23505494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Metabolomic and Lipidomic Serum Signature from Nonhuman Primates Administered with a Promising Radiation Countermeasure, Gamma-Tocotrienol.
    Cheema AK; Mehta KY; Fatanmi OO; Wise SY; Hinzman CP; Wolff J; Singh VK
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29283379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Romiplostim (Nplate
    Bunin DI; Bakke J; Green CE; Javitz HS; Fielden M; Chang PY
    Int J Radiat Biol; 2020 Jan; 96(1):145-154. PubMed ID: 31021662
    [No Abstract]   [Full Text] [Related]  

  • 18. Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents.
    Singh VK; Romaine PL; Newman VL; Seed TM
    Expert Opin Ther Pat; 2016 Dec; 26(12):1399-1408. PubMed ID: 27610458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IPW-5371 Proves Effective as a Radiation Countermeasure by Mitigating Radiation-Induced Late Effects.
    Rabender C; Mezzaroma E; Mauro AG; Mullangi R; Abbate A; Anscher M; Hart B; Mikkelsen R
    Radiat Res; 2016 Nov; 186(5):478-488. PubMed ID: 27841740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonhuman primates as models for the discovery and development of radiation countermeasures.
    Singh VK; Olabisi AO
    Expert Opin Drug Discov; 2017 Jul; 12(7):695-709. PubMed ID: 28441902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.